CLASS II ONGOING Device recall · Reported 14 Dec 2022 · FDA Enforcement Report

Propel Mini Mometasone Furoate Sinus Implant recalled by Intersect ENT

Intersect ENT is recalling Propel Mini Mometasone Furoate Sinus Implant, with Straight Delivery System, distributed nationwide in the US. The recall was initiated on 21 Oct 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesREF: 60044, UDI-DI: M927600440, Lot: 22041901
Quantity recalled611 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0458-2023
FDA event ID
91063
Recalling firm
Intersect ENT, Menlo Park, CA
Classification
Class II
Status
Ongoing
Recall initiated
21 Oct 2022
FDA classified
8 Dec 2022
Reported
14 Dec 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

21 Oct 2022Recall initiated by company
8 Dec 2022Classified by FDA+48 days
14 Dec 2022Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Sinus Implant product label displays incorrect product information including: "Straight Delivery System", with incorrect reference number and UDI-DI.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Propel Mini Mometasone Furoate Sinus Implant, with Straight Delivery System, REF 60044

Where it was distributed

US Nationwide distribution including in the states of NC, IL, KS, OR, WI, TX, FL, MN, WY, UT, NY, CA, NJ, OK, MD, HI, MT, TN, MO, IA, MA, AZ, GA, LA, ID, SC, WA, SD, ND, CO, NV.

Nationwide ArizonaCaliforniaColoradoFloridaGeorgiaHawaiiIowaIdahoIllinoisKansasLouisianaMassachusettsMarylandMinnesotaMissouriMontanaNorth CarolinaNorth DakotaNew JerseyNevada

Questions about this recall

Why was it recalled?

Sinus Implant product label displays incorrect product information including: "Straight Delivery System", with incorrect reference number and UDI-DI.

Which lots are affected?

REF: 60044, UDI-DI: M927600440, Lot: 22041901

Where was it sold?

US Nationwide distribution including in the states of NC, IL, KS, OR, WI, TX, FL, MN, WY, UT, NY, CA, NJ, OK, MD, HI, MT, TN, MO, IA, MA, AZ, GA, LA, ID, SC, WA, SD, ND, CO, NV.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Intersect ENT

All 2
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIISinuva (mometasone furoate) sinus implant, 1350 mcg, 1 implant recalledSinuvaIntersect ENTPotency & AssayNationwide

Other Other Medical Devices recalls

All 13,884